Indication

CLDN18.2

1 clinical trial

1 product

1 drug

Clinical trial

Two Stage, Multi-center Trial of Candonilimab in Combination With LM-302 for Treatment of Patients With Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody

Status: Recruiting, Estimated PCD: 2025-08-01

Product

Drug